1. Home
  2. WHD vs RCUS Comparison

WHD vs RCUS Comparison

Compare WHD & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

HOLD

Current Price

$47.10

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$25.69

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHD
RCUS
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
WHD
RCUS
Price
$47.10
$25.69
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$47.75
$28.88
AVG Volume (30 Days)
525.2K
1.8M
Earning Date
10-29-2025
10-28-2025
Dividend Yield
1.19%
N/A
EPS Growth
N/A
N/A
EPS
2.52
N/A
Revenue
$1,089,969,000.00
$240,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$33.92
N/A
P/E Ratio
$18.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.20
$6.50
52 Week High
$65.75
$26.40

Technical Indicators

Market Signals
Indicator
WHD
RCUS
Relative Strength Index (RSI) 71.46 71.29
Support Level $45.06 $24.32
Resistance Level $46.72 $26.40
Average True Range (ATR) 1.60 1.36
MACD 0.35 -0.06
Stochastic Oscillator 95.94 86.19

Price Performance

Historical Comparison
WHD
RCUS

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: